Abstract:Background: MicroRNA-155-5p (miR-155-5p) has been reported to play an oncogenic role in different human malignancies; however, its role in Wilms tumor (WT) remains unclear. Methods: Differentially expressed miRNAs (DE-miRNAs) and mRNAs (DEGs) in WT blood and tissues were identified by using miRNA microarray and RNA-sequencing. Bioinformatics prediction and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were used to predict the potential functions of DE-miRNAs. DE-miRNAs and DEGs in WT obtained from Gene Expression Omnibus (GEO) and Therapeutically Applicable Research to Generate Effective Treatments (TARGET) were identified by using the "edgeR" package. RT-qPCR was used to explore miR-155-5p and IGF2 expression and their clinical significance in WT specimens. A rhabdoid cell line (G401) and Ewing sarcoma cell line (SK-NEP-1) were used. Immunohistochemical staining, western blotting and dual-luciferase reporter assays were performed to study the mechanisms involved. The CCK-8, flow cytometry, wound healing and transwell assays were performed to identify the effects of miR-155-5p and IGF2 knockdown on cell proliferation, apoptosis, migration and invasion, respectively. Results: MiR-155-5p was downregulated in both blood and tissues from WT patients who did not receive chemotherapy before surgery but was upregulated in tissues from WT patients who had received chemotherapy before surgery. IGF2, PI3K, AKT and mTOR were found to be upregulated in WT tissues. Additionally, miR-155-5p and IGF2 were significantly correlated with TNM stage and lymphatic metastasis in WT patients. Molecular mechanism exploration indicated that IGF2 was downregulated by miR-155-5p via direct binding to its 3' untranslated region in cell lines. Furthermore, IGF2, PI3K, AKT and mTOR expression was inversely correlated with miR-155-5p expression, and PI3K, AKT and mTOR expression was positively correlated with IGF2 expression in cell culture. Functional studies demonstrated that miR-155-5p upregulation and IGF2 knockdown suppressed cell proliferation, migration and invasion and induced cell apoptosis. Moreover, the tumor-suppressing effects of miR-155-5p in cells were abrogated by miR-155-5p inhibitor treatment. Conclusions: Taken together, these findings suggest that miR-155-5p functions as a tumor suppressor in WT through inactivating the PI3K/AKT/mTOR signaling pathway by directly targeting IGF2. Thus, miR-155-5p might be a novel therapeutic target for WT.

HnRNPL Promotes Wilms Tumor Progression by Regulating the P53 and Bcl2 Pathways.

KHSRP modulated cell proliferation and cell cycle via regulating PPP2CA and p27 expression in Wilms tumor

MiR-22-3p Regulates the Proliferation and Invasion of Wilms' Tumor Cells by Targeting AKT3.

MiR-155-5p Exerts Tumor-Suppressing Functions in Wilms Tumor by Targeting IGF2 Via the PI3K Signaling Pathway.

Investigating the Dysfunctional Pathogenesis of Wilms' Tumor Through a Multidimensional Integration Strategy.

Comprehensive Analysis of a Long Noncoding RNA-Associated Competing Endogenous RNA Network in Wilms Tumor

Role of the Wilms' Tumor 1 Gene in the Aberrant Biological Behavior of Leukemic Cells and the Related Mechanisms.

Up-regulation of Mir-190B Promoted Growth, Invasion, Migration and Inhibited Apoptosis of Wilms' Tumor Cells by Repressing the PTEN Expression.

Long Non-Coding RNA XIST Promotes Wilms Tumor Progression Through the Mir-194-5p/yap Axis.

Nephroblastoma-specific dysregulated gene SNHG15 with prognostic significance: scRNA-Seq with bulk RNA-Seq data and experimental validation

ZMIZ1 Affects Invasion and Metastasis of Wilms Tumor by Regulating Notch Signaling Pathway

Comprehensive Analysis of the Long Non-Coding RNA-associated Competitive Endogenous RNA Network Reveals Novel Prognostic Biomarkers in Wilms' Tumor.

A Survival-Related Competitive Endogenous RNA Network of Prognostic Lncrnas, Mirnas, and Mrnas in Wilms Tumor

CCNB1 is a Novel Prognostic Biomarker and Promotes Proliferation, Migration and Invasion in Wilms Tumor.

Silencing of Lncrna MEG8 Represses the Viability, Migration, and Invasion of Wilms’ Tumor Cells Through Mediating Mir-23A-3p/crk Axis

Comprehensive analysis of long non‑coding RNA using an associated competitive endogenous RNA network in Wilms tumor

Heterogeneous Nuclear Ribonucleoprotein K is Associated with Poor Prognosis and Regulates Proliferation and Apoptosis in Bladder Cancer

RNA Sequencing Reveals a Regulatory Network of Circrna-Mirna-mrna Cerna in Wilms Tumor

HNRNPL Increases WSB1 mRNA Stability to Promote Proliferation and Lipid Droplets in Clear Cell Renal Cell Carcinoma

[Expression of miR-155-5p in Wilms tumor and its regulatory role in proliferation, migration and apoptosis of Wilms tumor cells in vitro].

Cyclin B1 is a Novel Prognostic Biomarker and Promotes Proliferation, Migration and Invasion in Wilms Tumour